Inhibition of the metalloprotease ADAM19 as a novel senomorphic strategy to ameliorate gut permeability and senescence markers by modulating senescence-associated secretory phenotype (SASP)
Sudipta Bar(Buck Institute for Research on Aging), Amit Sharma(Fertility & Lifespan Medical Institute)
Cited by 0